Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| human prostate cancer |
|
Human Prostate Cancer Tissue Arrays - Biocompare Buyer's Guide (5) » Human Cancer Tissue A » Human Prostate Cancer Back up one level Other Human Prostate Cancer Tissue Arrays Companies: The Biotech Weblog: Snake Venom Toxin Inhibits Human Prostate Blog this at your site Snake Venom Toxin Inhibits Human Prostate Cancer Cell Growth:. Login*, Password*. Your blog system. Typepad, Moveable Type, Wordpress Reactive Stroma in Human Prostate Cancer: Induction of calponin (G) staining was high in the smooth muscle cells of normal prostate stroma. Reactive stroma in human prostate cancer showed elevated Prostate Cancer Research Institute In this study the authors investigated the effect of intra-peritoneal injections of different catechins on the growth of human prostate cancer cell lines Therapeutic potential of curcumin in human prostate cancer-I Therapeutic potential of curcumin in human prostate cancer-I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer YY1: NOVEL PROGNOSTIC FACTOR IN HUMAN PROSTATE CANCER BACKGROUND: The initial development and progression of prostate cancer involve multiple molecular alterations. In tumor cells, genetic alterations and Methods of simulating human prostate cancer progression - Patent The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses Cancer Letters : Gene expression in the LNCaP human prostate Gene expression in the LNCaP human prostate cancer progression model: Progression associated expression in vitro corresponds to expression changes LEE BIOSOLUTIONS (PSA) HUMAN PROSTATE SPECIFIC ANTIGEN HIGH PURITY Higher than normal levels of human tumor marker Prostate Specific Antigen(PSA) are associated with both localized and metastatic prostate cancer (CaP). Oncogene - Abstract of article: Diallyl trisulfide-induced Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun Using PC-3 and DU145 human prostate cancer cells as a model, Pectin induces apoptosis in human prostate cancer cells Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure. Crystal L Jackson2,3, Tina M Dreaden2,3, Inhibition of Growth of Human Prostate Cancer Xenograft by p53 gene therapy in human prostate cancer xenografts using. this electroporation system. The human prostate cancer cell line PC-3 was cultured in Inorganic Arsenic and Human Prostate Cancer Inorganic Arsenic and Human Prostate Cancer, Location: Main Section of EHP Online. Human prostate cancer risk factors ronmental risk factors for human prostate cancer. It This model closely resembles the progression of human prostate cancer from the The human prostate cancer cell line LNCaP bears functional The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. Human prostate cancer risk factors. This review is a contemporary and comprehensive, literature-based analysis of the putative risk factors for human prostate cancer, and the results were Prostate - Wikipedia, the free encyclopedia A healthy human prostate is slightly larger than a walnut. Prostate cancer is one of the most common cancers affecting older men in developed countries |
| human prostate cancer |
|
prostate cancer complications new york city prostate massage healthy prostateovary lupron hormonal prostate treatment |